This article was originally published in The Tan Sheet
Fertility monitor distributed by Unipath Diagnostics reaches drug store shelves the week of March 1, retailing at $199.99 with a $25 introductory rebate. The handheld monitor, which tracks estrogen and luteinizing hormone levels in a woman's urine, cleared FDA Oct. 30 ("The Tan Sheet" Nov. 9, 1998, p. 13). FDA also signs off on a 510(k) Feb. 24 for the company's ClearPlan Data Transfer software that can download up to six months of fertility level and sexual event information from the monitor into a Windows-based format for review by a fertility specialist. The software, which is expected to be available in May through the company, should retail for approximately $100, Unipath says
You may also be interested in...
Perrigo promotes in pricing, planning
Combe sells most of its OTC brands
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC